Percent Of Deaths Research Articles

Change in the Proportion of Death at Home during the COVID-19 Pandemic and Its Associated Factors in the Municipality Level: A Nationwide Study in Japan.

The coronavirus disease 2019 (COVID-19) pandemic may have led to an increase in home deaths due to hospital bed shortage and hospital visitation restrictions. This study aimed to examine changes in the proportion of home deaths before and after the COVID-19 pandemic and identify associated factors. We used publicly available nationwide data to describe the proportion of home deaths among total deaths from 2015 to 2021. Furthermore, we used municipal-level data to examine the factors associated with the increase in the proportion of home deaths from 2019 to 2021. The dependent variable was the absolute change in the proportion of home deaths from 2019 to 2021. The independent variables included each municipality's 2019 home death percentage, medical and long-term care (LTC) resources divided by the population of older people, population density, and cumulative number of COVID-19 cases. A multivariable linear regression analysis was conducted after the standardization of each variable. The proportions of home deaths in 2015, 2019, and 2021 were 12.7%, 13.6%, and 17.2%, respectively, indicating a sharp increase in home death rate after the COVID-19 pandemic. In the multivariable linear regression analysis that included 1,696 municipalities, conventional home care support clinics and hospitals (HCSCs) (coefficient [95% confidence intervals (CIs)], 0.19 [0.01-0.37]), enhanced HCSCs (0.53 [0.34-0.71]), home-visiting nurses (0.26 [0.06-0.46]), population density (0.44 [0.21-0.67]), and cumulative COVID-19 cases (0.49 [0.27-0.70]) were positively associated with the increase in home deaths, whereas beds of LTC welfare facilities (-0.55 [-0.74--0.37]) and the proportion of home deaths in 2019 (-1.24 [-1.44--1.05]) were negatively associated with the increase. During the COVID-19 pandemic, home deaths significantly increased, particularly in densely populated areas with high cumulative COVID-19 cases. HCSCs, especially enhanced HCSCs, are crucial for meeting the demand for home-based end-of-life care.

The effect of the COVID-19 pandemic on the trends and characteristics of natural and unnatural deaths in an urban Sri Lankan cohort viewed through retrospective analysis of forensic death investigations from 2019 to 2022.

The coronavirus disease 2019 (COVID-19) pandemic has had a severe impact on global health. Apart from the disease itself, the strict restrictions and lockdowns enforced to minimize its spread have also substantially disrupted personal and public health. An analysis of forensic autopsy investigations was conducted between 2019 and 2022 on a selected urban population in Colombo, Sri Lanka, assessing the effects of the COVID-19 pandemic on mortality within these communities. During the COVID-19 restrictions, there was a 2.5-fold increase in the total number of deaths, with a significantly higher percentage of female deaths than before. The majority of these deaths were due to cardiovascular causes, while COVID-19-related deaths ranked third overall. The highest proportion of COVID-19 deaths occurred among unvaccinated females. The monthly frequency of deaths from traffic accidents, poisoning, and asphyxiation decreased, while deaths from blunt trauma, sharp trauma, burns, and immersion increased. There was also a rise in blunt homicides and a greater number of femicides during the COVID-19 restrictions than in the pre-pandemic period. A significantly higher percentage of males who received the COVID-19 vaccine died from cardiovascular causes compared to those in the unvaccinated group. The significant changes in mortality demographics and causes of death within this community during the COVID-19 restrictions underscore the disruption in healthcare, healthseeking behavior, and social interactions during this period. The vulnerability of individuals residing in highly urbanized areas with lower socioeconomic status, particularly women, is brought into sharp focus.

Test The Toxicity of The Ethanol Extract of Lacum Leaves (Cayratia trifolia L.) Using The Brine Shrimp Lethality Test (BSLT) Method

People use the lacum plant (Cayratia trifolia L.), an herbaceous plant from the Vitaceae family that grows wild, as a traditional medicine. Lacum leaves have special things inside them called secondary metabolites like flavonoids, alkaloids, phenols, steroids, terpenoids, and tannins. Toxicity tests must be carried out because flavonoids, alkaloids and steroids have harmful effects on test animals at certain concentrations. A substance or natural ingredient that will be used as a medicine is tested to determine its level of toxicity. The purpose of this study was to determine the total levels of toxic compounds and the level of toxicity in the ethanol extract of lacum leaves (Cayratia trifolia L.) Brine Shrimp Lethality Test (BSLT). This research uses Artemia salina leach larvae as test subjects. This research also used an experimental approach arranged in a completely randomized design (CRD) consisting of 7 treatments and 4 replications. The percentage of larval death was used in probit analysis to identify the toxic effects of the extract and calculate the LC50 value. Based on the research results, it shows that there are total levels of toxic compounds in the ethanol extract of lacum leaves (Cayratia trifolia L.), namely flavonoids, alkaloids and steroids with an LC50 value of 105.08 ppm which places it in the moderately toxic category and is thought to have anticancer properties.

Synthesis of silver nanoparticles from marine bacteria and evaluation of antimicrobial, antifungal and cytotoxic effects

BackgroundMarine bacteria, a relatively untapped resource, have shown potential for synthesizing nanoparticles with distinct properties. MethodsThe AgNPs were synthesized by using the marine bacteria Planococcus maritimus MBP-2 as a reducing and capping agent. The nanoparticles produced were characterized by UV–Vis spectroscopy, TEM and FTIR. The Planococcus maritimus MBP-2 synthesized AgNPs adhered antibacterial activity against selected both gram-negative and gram-positive bacteria such as Staphylococcus aureus, Bacillus cereus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, and antifungal such Aspergillus niger, Aspergillus flavus, Penicillium commune and Penicillium digitatum. and the cytotoxic effect of Dalton’s Lymphoma Ascites (DLA) cell lines. ResultsThe formation of AgNPs by bacteria was confirmed visually by a shift in color of the solution and the presence of UV-absorption maxima at 440 nm. The TEM images revealed spherical and cubic structures, with an average size of 24.9 nm. FTIR analysis confirmed the presence of some functional groups by showing peaks at 3330 and 1636 cm−1. The AgNPs exhibited minimal antibacterial activity except P. aeruginosa. (11 mm). Whereas, inhibiting the growth of the fungi belonging to genus Aspergillus than to Penicillium. Also, in vitro cytotoxicity of AgNPs was evaluated using Dalton’s Lymphoma Ascites (DLA) cell lines. The percentage of cell death was maximum (95.4 ± 2.16) at 20 µg/mL, indicating an excellent cytotoxic efficiency of AgNPs against DLA cells from the peritoneal cavity of the tumor-bearing mouse. ConclusionThis study suggests that Planococcus maritimus MBP-2 bacteria-mediated AgNPs can effectively be used as a potential biomedical agent.

Homeopathic dilutions of Phytolacca decandra induce cytotoxicity of human breast adenocarcinoma cells

Breast cancer is a malignant tumor frequently diagnosed in the female population that representsthe main cause of cancer death in women worldwide. Recently, the use of complementary therapiessuch as homeopathy has increased to alleviate the side effects of conventional allopathic treatments.However, the cellular and molecular effects of homeopathic medicaments have not been fullyclarified. Thus, the aim of this work was to evaluate the in vitro effects of Phytolacca decandrahomeopathic preparations on human breast adenocarcinoma cells. For this, MCF-7 breastadenocarcinoma cells were cultivated in the presence or absence of Phytolacca decandra mothertincture (PdTM) or centesimal Hahnemannian dilution (CH) of Phytolacca decandra: 30 or 200 CH.Determination of apoptosis and necrosis percentages, cytokine production and morphologicalchanges were evaluated after 24, 48 and 72 hours of culture in each of the treatments. Resultsobtained in cytotoxicity analyses showed a higher percentage of death in cells treated withhomeopathic dilutions, with similar results to that presented by cells treated with Doxorubicin orPdTM. In contrast, cells treated with homeopathic dilutions of Phytolacca decandra did not showmarked differences in the production of pro and anti-inflammatory cytokines when compared tountreated. Similarly, analyses of cell morphology did not display significant differences before andafter treatment with homeopathic dilutions, when compared to untreated cells. Already, cells treatedwith PdTM presented marked cellular alterations with observation of apoptotic bodies in the threeevaluated times. Together, results show that homeopathic dilutions of Phytolacca decandra inducedcytotoxicity of human breast adenocarcinoma cells in the absence of inflammatory process.

Explaining the increase of incidence and mortality from cardiovascular disease in Indonesia: A global burden of disease study analysis (2000–2019)

Background In the last two decades, there has been a discernible shift in the distribution of mortality attributed to cardiovascular disease (CVD) between developing and developed nations; in developed nations, the percentage of deaths caused by CVD decreased from 48% in 1990 to 43% in 2010, while in developing nations, they increased from 18% to 25%. In Indonesia, CVD death has increased substantially and remained elevated in the last ten years. Current behavioral and metabolic risk factors, including hyperglycemia, obesity, dyslipidemia, hypertension, and smoking, enhance the risk of CVD mortality, according to several studies. Aims We undertook a study to determine whether the increase in mortality and incidence of CVD can be attributed to changes in the most common metabolic and behavioral risk factors from 2000 to 2019 across 34 Indonesian provinces. Materials and methods Data from 34 province for CVD incidence and mortality and data on changes in metabolic and behavioural risk factors between 2000 and 2019 in Indonesia were obtained from the Global Burden study (GBD) by The Institute of Health Metrics and Evaluation (IHME). A statistical model was applied to calculate the fatalities attributable to the risk factors change using Population attributable fractions (PAF) and baseline year death numbers. Furthermore, we ran multivariate regressions on Summary Exposure Value of risk factors associated with the increasing mortality, incidence rates in a lag year analysis. R software used to measure heteroscedasticity-consistent standard errors with coeftest and coefci. Covariates were added to adjusted models, including the Socio-demographic Index, Primary health care facilities coverage, and GDP per capita. Results The age-standardized mortality rate for CVD from 2000 to 2019 in Indonesia, increased from 356.05 to 412.46 deaths per 100,000 population among men and decreased from 357.52 to 354.07 deaths per 100,000 population among women, resulting in an increase of 270.928 per 100,0000 inhabitants of CVD deaths. In the same period, there was an increase in exposure to risk factors such as obesity by +9%, smoking by +1%, dyslipidemia by +1.3%, hyperglycemia by +2%, and hypertension by +1.2%. During this time span, an additional 14,517 men and 17,917 women died from CVD, which was attributable to higher obesity exposure. We apply multivariate regression with province-fixed and year-fixed analysis and find strong correlation between hyperglycemia in women (6; 95%CI 0 to 12, death per 1-point increase in hyperglycemia exposure) with an increasing death rate in ischemic heart disease. We also performed a year lag analysis and discovered a robust association between high low density lipoprotein (LDL) levels in men and women and the growing incidence of ischemic heart disease. The association between a 10-year lag of high LDL and the incidence of ischemic heart disease was five times stronger than that observed for other risk factors, particularly in men (5; 95%CI 2 to 8, incidence per 1-point increase in high LDL exposure). Conclusion Hyperglycemia in women is an important risk factor associated with increasing mortality due to Ischemic Heart Disease (IHD) in Indonesia This study also revealed that the presence of high LDL in both men and women were associated with an increase incidence of IHD that manifested several years subsequent to exposure to the risk factor. Additionally, the highest cardiovascular death portion were attributed to obesity. These findings suggest that policymakers should control high LDL and hyperglycemia 10 years earlier prior to the occurrence of IHD and employ personalized therapy to regulate associated risks.

Delineating Pixantrone Maleate’s adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation

Cervical cancer poses a substantial worldwide health challenge, especially in low- and middle-income nations, caused by high-risk types of human papillomavirus. It accounted for a significant percentage of cancer-related deaths among women, particularly in areas with limited healthcare resources, necessitating innovative therapeutic approaches, and single-targeted studies have produced significant results, with a considerable chance of developing resistance. Therefore, the multitargeted studies can work as a beacon of hope. This study is focused on performing the multitargeted molecular docking of FDA-approved drugs with the three crucial proteins TBK1, DNA polymerase epsilon, and integrin α-V β-8 of cervical cancer. The docking studies using multisampling algorithms HTVS, SP, and XP reveal Pixantrone Maleate (DB06193) as a multitargeted inhibitor with docking scores of -8.147, -8.206 and -7.31 Kcal/mol and pose filtration with MM\GBSA computations with scores -40.55, -33.67, and -37.64 Kcal/mol. We also have performed QM-based DFT and pharmacokinetics studies of the compound and compared it with the standard values, which results in the compound being entirely suitable against cervical cancer proteins. The interaction fingerprints have revealed that PHE, VAL, SER and ALA are the residues among most interactions. We also explore the stability of the multitargeted potential of Pixantrone Maleate through 100ns MD simulations and investigate the RMSD, RMSF and intermolecular interactions between all three proteins-ligand complexes. All computational studies favour Pixantrone Maleate as a multitargeted inhibitor of the TBK1, DNA polymerase epsilon, and integrin α-V β-8 and can be validated experimentally before use.

MYCOPLASMATIC (ENZOOTIC) PNEUMONIA OF PIGS AS A HEALTH PROBLEM IN FATTENING UNITS

Mycopasmatic or enzootic pneumonia is the most common disease of the respiratory system under in the intensive pig production. It is clinically manifested by coughing, a chronic inflammatory process in the lungs, high morbidity and a relatively low percentage of deaths. The infection can be transmitted horizontally and vertically. Mycoplasma hyopneumoniae invades the epithelial cells of the trachea, bronchi, bronchioles and alveoli and disrupts the function of the ciliary body. Evagination of epithelial cells occurs, so that the cleansing of the airway mucosa by the mucociliary apparatus is inhibited. As a result, bacterial complications (Pasteurella, Bordetella, Klebsiella, Actinobacillus, Hemophilus) are common.M.hyopneminia can play imortant role in PRDC. The development of Mycoplasma hyopneumoniae is favoured by large congregations of pigs in small spaces, inadequate environmental conditions (microclimate), parasitic infections and inadequate nutrition. Mycoplasma hyopneumonia can be a significant health problem on the fattening farm, exacerbated by the influence of non-specific factors as well as the spread of other bacterial pathogens.

The efficiency of using integrated control agents to manage the Dubas bug Ommatissus binotatus lybicus De Berg (Homoptera: Tropiducidae) in Karbala Governorate

This study aims to rate the efficiency of using chemical pesticides, bio-fungicides, and the interaction between them against the nymphal and adult stages of the Dubas insect (Ommatissus binotatus lybicus De Berg). Anyhow, the laboratory and field results of the pesticides significantly affected the treated phases. The field results of the treatments were significantly increased after around two weeks, as for the average percentage of death in the treated nymphs. It reached 89.29-75.03-72.5-71, respectively. The results of the interaction treatments between fungal biocides (Beauveria bassiana, Paecilomyces sp, Beauveria bassiana, Metarhizium anisopliae, Metarhizium anisopliae, and Paecilomyces sp) were significantly increased after two weeks of treatment, as the average percentage of death of the treated nymphs reached 63.95 -77.19 -63.5, respectively. The laboratory results of the treatments were significant for the pesticides used after nine days of treatment, as the average percentage of death of the adults reached 86.01 - 39.25 -32.16 -36.81, respectively. Moreover, the interaction coefficients between the fungal biocides mentioned in the paragraph above were significant after nine days of treatment. The average percentage of treated adults' deaths reached 38.13 -39.64 37.57 - 86.02 to treat the interaction between the chemical pesticide Actara and B. bassiana. The chemical pesticide Actara excelled in the field experiment, as it gave the highest percentage of mortality when used at concentrations of 1-1.5 g/L after two weeks of treatment. The average percentage of nymphs killed was 89.29.
 As for the laboratory experiment results, the chemical pesticide Actara was also superior, as it gave the highest mortality rate for adult females. The average mortality rate for adult females reached 86.01 after nine days of treatment compared to the rest of the treatments using other pesticides.

The power of mumps virus: Matrix protein activates apoptotic pathways in human colorectal cell lines

New therapeutic approaches can significantly impact the control of colorectal cancer (CRC), which is increasing worldwide. In this study, we investigated the potential of targeting viral proteins to combat cancer cells. Specifically, we examined the anticancer potential of the matrix (M) protein of the mumps virus Hoshino strain in SW480 CRC cell lines. To begin, we individually transfected SW480 cells with pcDNA3 plasmids containing the mumps virus M gene. We then investigated the percentage of cell death, caspase activity, and the expression levels of genes involved in apoptosis pathways. Following this, we performed bioinformatics analysis on the M protein to identify any similarities with Bcl-2 family members and their viral homologs. Our diagnostic methods showed that treatment with the mumps M protein induced apoptosis and upregulated the expression and activity of pro-apoptotic proteins in SW480 CRC cells compared to the control and vector groups. Based on our bioinformatics studies, we proposed that the BH3 motif in the M protein may trigger apoptosis in CRC cells by interacting with cellular Bax. Overall, our study showed for the first time that the mumps virus M protein could be considered as a targeted treatment for CRC by inducing apoptotic pathways.

Artificial intelligence with machine learning and the enigmatic discovery of HIV cure

<p>HIV’s complexity has long presented a problem in the quest for a cure. However, the development of machine learning (ML) and artificial intelligence (AI) technology has opened up promising new directions for HIV cure research. This study investigates the impact of AI and ML on the discovery and development of an HIV cure to shed light on their potential role in hastening advancements in this field. The study employs quantitative methodology, and the execution of the methods is achieved by using AI and ML techniques for analysis processes and presenting the study’s findings by utilizing the Kaggle.com HIV dataset, where pertinent features are found for the machine learning algorithm. Additionally, advanced statistical techniques, such as Structural Equation Modeling (SEM), to investigate the causal link between AI and ML utilization and the development of a cure for HIV is utilized. The robustness of the analysis is enhanced by using Penalized Ridge and Lasso Regressions. The study utilizes logistic regression as the machine learning model, and the mean square error is used to evaluate performance. Control variables, including the year, borough, the Uniform Hospitalization Fund (UHF) code, gender, age, race, concurrent diagnoses, percentage linked to care within three months, the prevalence of (People living with HIV/AIDS) PLWDHI, and percentage of viral suppression, deaths, death rate, and HIV-related death rate are all taken into consideration, to ensure a thorough analysis. This study finds that AI and ML are the future of the healthcare sector, providing promising opportunities for finding a cure for HIV and enhancing patient care. Further, the study confirms that new targets for HIV cure research can be found by utilizing AI and ML, and treatment outcomes and individualized treatment plans can also be developed. AI and ML can also enhance clinical trials, boost HIV prevention efforts, and lower the number of new infections.</p>

A French nationwide study compared various conditions and healthcare use of individuals < 65 years with a Down’s syndrome to those without

Few regular national clinical data are available for individuals with Down’s syndrome (IDS) bearing in mind that they are subject to countries variations in medical termination of pregnancy and screening. Individuals < 65 in 2019 were selected in view of the low number of older IDS. Thus, 98% of 52.4 million people with correct data were included from the national health data system. IDS (35,342) were identified on the basis of the International Classification of Diseases 10th revision code (Q90). Risk ratios (RR) were calculated to compare the frequencies in 2019 between IDS and individual without Down’s syndrome (IWDS) of use of health care. The prevalence of IDS was 0.07% (48% women), comorbidities were more frequent, especially in younger patients (24% < 1 year had another comorbidity, RR = 20), as was the percentage of deaths (4.6%, RR = 10). Overall, tumours were less frequent in IDS compared with IWDS (1.2%, RR = 0.7) except for certain leukaemias and testicular tumours (0.3%, RR = 4). Cardiac malformations (5.2%, RR = 52), dementia (1.2%, RR = 29), mental retardation (5%, RR = 21) and epilepsy (4%, RR = 9) were also more frequent in IDS. The most frequent hospital diagnoses for IDS were: aspiration pneumonia (0.7%, RR = 89), respiratory failure (0.4%, RR = 17), sleep apnoea (1.1%, RR = 8), cryptorchidism (0.3%, RR = 5.9), protein-energy malnutrition (0.1%, RR = 7), type 1 diabetes (0.2%, RR = 2.8) and hypothyroidism (0.1%, RR = 72). IDS were more likely to use emergency services (9%, RR = 2.4), short hospital stay (24%, RR = 1.6) or hospitalisation at home (0.6%, RR = 6). They consulted certain specialists two to three times more frequently than IWDS, for example cardiologists (17%, RR = 2.6). This study is the first detailed national study comparing IDS and non-IDS by age group. These results could help to optimize prenatal healthcare, medical and social support.

Computer simulation of two phase power-law nanofluid of blood flow through a curved overlapping stenosed artery with induced magnetic field: entropy generation optimization

PurposeThe purpose of this study is to determine the impact of two-phase power law nanofluid on a curved arterial blood flow under the presence of ovelapped stenosis. Over the past couple of decades, the percentage of deaths associated with blood vessel diseases has risen sharply to nearly one third of all fatalities. For vascular disease to be stopped in its tracks, it is essential to understand the vascular geometry and blood flow within the artery. In recent scenarios, because of higher thermal properties and the ability to move across stenosis and tumor cells, nanoparticles are becoming a more common and effective approach in treating cardiovascular diseases and cancer cells.Design/methodology/approachThe present mathematical study investigates the blood flow behavior in the overlapped stenosed curved artery with cylinder shape catheter. The induced magnetic field and entropy generation for blood flow in the presence of a heat source, magnetic field and nanoparticle (Fe3O4) have been analyzed numerically. Blood is considered in artery as two-phases: core and plasma region. Power-law fluid has been considered for core region fluid, whereas Newtonian fluid is considered in the plasma region. Strongly implicit Stone’s method has been considered to solve the system of nonlinear partial differential equations (PDE’s) with 10–6 tolerance error.FindingsThe influence of various parameters has been discussed graphically. This study concludes that arterial curvature increases the probability of atherosclerosis deposition, while using an external heating source flow temperature and entropy production. In addition, if the thermal treatment procedure is carried out inside a magnetic field, it will aid in controlling blood flow velocity.Originality/valueThe findings of this computational analysis hold great significance for clinical researchers and biologists, as they offer the ability to anticipate the occurrence of endothelial cell injury and plaque accumulation in curved arteries with specific wall shear stress patterns. Consequently, these insights may contribute to the potential alleviation of the severity of these illnesses. Furthermore, the application of nanoparticles and external heat sources in the discipline of blood circulation has potential in the medically healing of illness conditions such as stenosis, cancer cells and muscular discomfort through the usage of beneficial effects.

Qualitative and quantitative characteristics of xylazine-associated deaths detected using a post-mortem toxicology testing program

Introduction The United States drug overdose crisis continues to evolve. Xylazine has been increasingly identified as an adulterant in illicit opioid supplies. The incorporation of novel adulterants, like xylazine, into the illicit drug supply adds complexity to post-mortem toxicology testing, public health messaging, substance use mitigation, and the treatment of people who use drugs. Methods We assessed trends, decedent characteristics, drug co-detection, and blood concentrations of xylazine-positive post-mortem cases in Michigan. We utilized a toxicology testing program capable of detecting several opioids and non-opioids in post-mortem blood samples within 72 hours. Results A total of 279 deaths were xylazine-positive between October 2019 and June 2023, with 100 percent positive for fentanyl. Only 30 percent of xylazine-involved samples were positive for naloxone, while 21.2 percent of xylazine-negative and opioid-positive samples were positive for naloxone. The percentage of xylazine-positive deaths increased from 3.2 percent in 2021 to 4.7 percent in January–June 2023. A median of five total drug groups were present among xylazine-positive deaths. Post-mortem xylazine concentrations for 55 decedent blood samples ranged from 5.2 to 200 µg/L. Discussion Our study demonstrated increases in xylazine detection among post-mortem cases. Our findings are consistent with national trends of increasing xylazine presence among drug-involved deaths. Our range of detected post-mortem xylazine blood concentrations was consistent with what has been reported in previous literature. Fentanyl was detected in 100 percent of xylazine-positive overdose deaths. Naloxone detection was relatively low, highlighting the continued importance of increasing naloxone access and distribution. Deaths associated with xylazine often involved multiple other drugs. Limited human clinical xylazine research precludes accurate interpretation and attribution of causality from these data. Conclusions Overdose-related deaths with xylazine detection are increasing in Michigan and across the United States. Further clinical and toxicological research can help contextualize the clinical significance of xylazine in opioid overdose, clarify epidemiologic and clinical research, and inform appropriate public health messaging.

Association of a Remote Blood Pressure Monitoring Program With Postpartum Adverse Outcomes

(Abstracted from Obstet Gynecol 2023;141:1163–1170) A large percentage of maternal complications and deaths in the United States are due to hypertensive disorders of pregnancy; although these complications gradually improve after delivery, there are cases where it takes months for blood pressure to return to normal. Research has shown that blood pressure typically peaks 3 to 7 days postpartum, meaning that many individuals experience peaks in their blood pressure that put them at risk for stroke or seizure after discharge from the hospital.

Hospitalization and mortality during the pandemic in chronic hemodialysis patients and the general population in Peru.

Patients with chronic kidney disease have a higher risk of severe disease and mortality from COVID-19 than the general population. To compare hospitalization and mortality rates during the pandemic among chronic hemodialysis (HD) patients and the general population in Lima (Peru). This retrospective cohort included an assessment of the database of chronic HD patients of the health service providers of the social health insurance benefit networks of Lima and Callao between 2019 and 2021. Hospitalization and mortality rates were obtained for every 1,000 individuals, and variations in the percentages of COVID-19 cases and deaths were calculated. These rates were compared with those of the general population data and standardized by age and sex. An average of 3,937 chronic HD patients were evaluated each month. Of these, 4.8% had COVID-19 and 64.97% were mild cases. The hospitalization rates per 1,000 patients were 19.5, 29.28, and 36.7 in 2019, 2020, and 2021, respectively. The mortality rates per 1,000 patients were 5.9, 9.74, and 11.49 in 2019, 2020, and 2021, respectively. When compared to the standardized general population, the peaks of both rates coincided with the plateaus of the waves during the pandemic. The hospitalization rate for COVID-19 was 12 times higher in HD patients than in the general population, and the mortality rate for COVID-19 was twice as high. HD patients had higher hospitalization and standardized mortality rates than the general population. Peaks in hospitalizations and mortality coincided with the plateaus of the first and second waves of the pandemic.

Toxicity Test of Ethanol Extract of Gagatan Harimau Leaves (Vitis Gracilis BL.) on Artemia Salina Leach Larvae Using Brine Shrimp Lethal Test (BSLT) Method

Gagatan harimau leaves (Vitis gracilis BL) is a plant contains several secondary metabolite compounds, namely alkaloids, glycosides, tannins, saponins and flavonoids and has been used traditionally to treat diarrhea, infectious diseases, inflammation and diabetes. The aim of this study was to to determine data on the percentage of deaths and the LC50 value of the ethanol extract of the Gagatan harimau (Vitis gracilis BL) against Artemia Salina Leach using the Brine Shrimp Lethality Test (BSLT) method. The method used is the Brine Shrimp Lethality Test (BSLT) with concentrations of 180 ppm; 200 ppm; 220ppm; 240ppm; 260ppm; 280ppm; 300 ppm and 0 ppm as negative controls each replicated three times. At each concentration, 10 Artemia salina Leach larvae were used as test animals, each concentration was 48 hours old. The toxic effect of the extract was determined by the percentage mortality of Artemia salina Leach larvae using probit analysis (LC50). The results of this research gave the linear regression equation Y = 11.674x-68.227. Therefore, the LC50 value is 6.275 and the LC50 gets a value is 187.068 ppm. Research on the toxicity of Gagatan harimau (Vitis gracilis BL.) ethanol extract using the BSLT (Brine Shrimp Lethality Test) method in this study is toxic because the LC50 is &lt; 1000 ppm so it has the potential to be anticancer.

Identification, evaluation the source of natural bioactive compounds from Calotropis gigantea l. flowers and their anticancer potential

BackgroundIn the intensified search to derive biologically active compounds from natural products for various health care issues, attention is focused on non-edible plant sources. Among the wild plants, Calotropis [milk weeds] of the family Apocynaceae, are the repository of pharmaceutically active phytoconstituents. The flowers of C. gigantea are expected to be rich in bioactive compounds. MethodsThe bioactive compounds and in vitro anticancer activity of C. gigantea flower extract were investigated. The compounds in the extract were separated using GC–MS and confirmed their structures with NIST (National Institute of Standard and Technology) database. The cytotoxicity of flower extracts against A-549 lung cancer cell lines was evaluated by MTT assay. Among the six identified compounds, three biologically active compounds with short retention time and abundance were chosen for molecular docking for anticancer activities. Molecular docking using the software GLIDE version 6.5 was used to trace their interactions with the anti-lung cancer protein, IT69. ResultsThe phytochemical screening indicated the rich presence of anticancer flavonoid and phenolic compounds in the flower extract. Inhibition of cell viability and growth and morphological alterations in cells were observed when A-549 cells were exposed to different concentrations of flower extract. The highest percentage of cell death (70 %) was observed in cells exposed to 100 µg/ml concentration. Molecular docking of three identified compounds with lung anticancer protein complex, IT69 proved that Butanoic acid, 3-[(phenyl methoxy) imino] trimethylsilyl ester is a good anti-lung cancer agent. Hence for pulmonary cancer, the identified compound can intensively be tested further.

Studies on Fixed Dose Combination of Ibrutinib and Quercetin Self-Nanoemulsifying Drug Delivery Systems in Human Cancer Cell Lines

Ibrutinib (IB), irreversibly inhibits Bruton’s tyrosine kinase which plays a crucial role in the tumor microenvironment and quercetin (QC) has shown apoptosis induction, angiogenesis inhibition, and anti-proliferative action against several human carcinoma cells. The self-nano-emulsifying drug delivery system (SNEDDS) is suitable for loading insolubilized oil-based compounds such as ibrutinib and quercetin. In the current study IB with QC was formulated into SNEDDS and cytotoxicity was determined by using human malignant melanoma (A-375) and human lung adenocarcinoma (A549) cell lines. The optimized loaded formula consisted of castor oil, Kolliphor® RH 40, and PEG-600. The optimized formulation was evaluated for physical parameters and the results were satisfactory. For cytotoxicity studies MTT assay was conducted for these combinations, IC50 values were calculated for the tested compound. In A-549 adenocarcinoma cell line, the calculated IC50 values (μM) for the test compounds T1 (pure IB ± QC) and T2 (IB ± QC SNEDDS) were 70.34 ± 0.8 and 85.46 ± 0.93 μM at 24 hours study, respectively. In A-375 cancer cell line, IC50 values for the compounds T1 and T2 were 59.52 ± 0.87 and 88.43 ± 1.03 μM for 24 hours study, respectively. It was observed that the IC50 of IB-QC loaded SNEDDS was higher than pure drug combination and these enter the cells by active transport and induce cytotoxicity to the cells. The overall results from the studies suggest that IB-QC-loaded SNEDD provided synergistic effects, which could play a significant role in the percentage of cell death.

Update Diagnosis and Treatment of Hemoptysis

Hemoptysis refers to the occurrence of bleeding that comes from a location situated below the voice chords. Typically, it is categorized as normal, mild, or major, with the latter referring to bleeding exceeding 200–600 mL (about 1-2 cups) within a 24-hour period. Massive hemoptysis refers to bleeding that is either hemodynamically significant or poses a threat to ventilation. In a single study, the percentage of deaths within the hospital was found to be 6.5%. The primary objective of managing extensive hemoptysis is to provide therapeutic interventions rather than focusing on diagnostic procedures. The majority of occurrences of hemoptysis observed in patients receiving treatment outside of a hospital setting are attributed to infection, such as acute or chronic bronchitis, pneumonia, tuberculosis, or aspergillosis. The purpose of this study is to provide information on the latest advancements in the diagnosis and treatment of hemoptysis symptoms.&#x0D;